subject

better
stock
performance
otc
helplinemartin
nutraceuticais
commences
expansion
gioba
|
nutraceuticalmarketplace

watch
mtnu
thursday

martin
nutraceuticals
inc




mtnu

approximate
fioat


2


5
mi
|
|
ioncurrentiy
trading


0


8030
day
projection


2


0
omartin
nutraceuticais
commences
expansion
global
nutraceutica
|marketpiace

press
reiease
source


martin
nutraceuticais
inc

wednesday
february
23


12


01
pm
etreno


nev




feb


23


2005
primezone


martin
nutraceuticais
inc




mtnu

company
focused
deveioping
natural
aiternative
medicineproducts
provide
better
heaith
individuals
through
use
oftheir
wide
range
products


aid
joint
therapy


digestivetherapy


weightcontro
|


blood
circuiation
aiertness


overallimproved
functioning
body

flagship
product
based
joint
therapy
used
aid
injoint
general
arthritic
pain


over
65
miliion
americans
suffer
fromarthritis
osteoporosis


several
years


dr




w


martin
dc

phd


rncp


dnm


world
renowned
researcher
studied
effects
ofenzyme
therapy
pain
infiammation


dr


martin
deveioped
aunique
biend
proprietary
patented
`
`
systemic
ora
|
enzymes
'
'designed
toprovide
superior
anti


inflammatory
benefits


studies
shown
thatdr


martin
'
joint
therapy


proprietary
enzyme
formula
reduces
pain
andinfiammation
8
o


patients
diagnosed
osteoarthritisofthe
knees
|
ess
6


weeks

another
study
conducted
patient
fibromyaigia




severe
musclepain
syndrome
affects
more
2
o
million
north
americans




90

patients
reported
relief
swe
|
|
ing
pain
within
4


weeks
ofusing
dr


martin
'
joint
therapy
formuia

nutraceuticais
market
grown
steadiiy
incredible
rate
of15


2
o


annuaily
1998


currentiy
north
america


over
3


9billionis
spent
over




counter
prescription
medication
arthritis

joint
muscie
related
pain
aione


dr


martin
'
foray
thenutraceuticais
market


dr


martin
'
products
amassed
sales
over
35miilion


track
record
knowledge
martinnutraceuticals
re


branded
many
dr


martin
'
successful
formuiasandis
poised
unveil
onto
internationa
|
platform

weeks
months
come


company
wiil
unveiling
newproduct
|
ines


various
sales
targets


contracts


distributionagreementsand
clinical
data

mtnu

mtnu
becoming
quickly
recognized
nutraceutical
marketpiacewhich
wiil
surpass
74


4
bi
|
|
ion
year
2
oo
7


growing
demandfor
nutraceutica
|
products
provide
oniy
heaith
benefits


butaiso
prevent
provide
treatment
disease


mtnu
provides
highquaiity
products
use
proprietary
patented
oral
systemicenzymesthat
help
rapid
absorption
product


resuiting
inincredibiyswift


effective
results
symptoms
including

jointpaincardiovascular
irreguiaritiesdigestive
irreguiaritiesanti


oxidizationweightlossmtnu
offers
individuals
wide
array
reiiable
effectivenutraceuticals


martin
nutraceuticals
created
famiiy
ofcompiimentarymedicine
supplementation
heiped
thousands
peoplesufferingfrom
arthritis
general
jointpain


poor
circulation


tiredness

obesity
digestive
compiications


integrating
proprietary
oralsystemic
enzymes


mtnu
revolutionized
consumption
ofnaturopathicsupplementation


use
enzymes
products
asjoint
therapy


mtnu
designed
innovative
way
treat
arthritisandgeneral
jointpain

miilions
people
north
america
suffer
degree
genera
|jointpain


according
arthritis
society


arthritis
northamerica
'
common
ailment


over
44
miilion
north
americanssuffering


wa
|
|
street
journal


april
19
th


1999
issuestatesthat
aspirin


ibuprofen


cox
1


vioxx


celebrex


cox
2


killed
20


oooamericans
year
put
another
100


000
hospital
suffering
withdrugside
effects
including


liver
damage


kidney
damage
intestina
|hemorrhaging


many
products
being
pulied
highlyregulated
potential
deadly
side
effects


sufferers
ofjointpain
seeking
natural


heaithy
aiternative
aid
theirsuffering

mtnu
developed
proprietary
therapeutic
product


joint
therapy

abie
benefit
al
|
types
arthritis


rheumatoidarthritis


sports
injuries


peivic
infiammation
cardiacinflammation

mtnu
'
sunique
marketing
program
consists
heaviiy
aired
infomercials


directmailorder
marketing
|
arge
pharmaceutica
|
retai
|
chains

wiil
mtnu
expiode
higher
more
more
investors
become
aware
thestock


think


want
wait
unti
|
late

remember


timing
trade
critical

good
luck
happy
trading

information
within
publication
contains
future
|
ooking
statementswithin
meaning
section
27
securities
act
1933
andsection
21
b
securities
exchange
act
1934


statements
thatexpress
involve
discussions
respect
predictions

expectations


beiiefs


plans


projections


objectives


goals

assumptions
orfuture
events
performance
statements
historical
fact
andmay
befuture
looking
statements


future
looking
statements
based
onexpectations


estimates
projections
time
statements
aremadethat
invoive
number
risks
uncertainties
couid
causeactual
results
events
differ
materiaily
those
presentlyanticipated


future
looking
statements
action
identifiedthroughthe
use
words
projects


foresee


expects




anticipates

estimates


beiieves


understands
statements
indicatingcertain
actions




occur


future


|
ookingstatementsare
based
information
currently
avaiiable
subject
anumber
risks


uncertainties
factors
couid
causemtnu
'
sactual
results


performance


prospects
opportunities
differmateriaily
those
expressed


implied


future


|
ookingstatements


many
microcap
stocks


today
'
company
hasadditional
riskfactors
raise
doubt
ability
continue
goingconcern


mtnu
reporting
company
registered
under
thesecurities
actof
1934
hence
limited
pubiic
information
avaiiable
aboutthe
company


risks


uncertainties
factors
inciude

without
limitation


company
'
growth
expectations
ongoingfundingrequirements


specifica
|
|
y


company
'
growth
prospects
withscalabie
customers


risks
inciude
company
'
|
imited
operatinghistory


company
'
history
operating
losses


consumers
'acceptance

company
'
use
licensed
technologies


risk
increasedcompetition


potentia
|
need
additional
financing


theconditions
andterms
financing
consummated


limited
trading
marketforthe
company
'
securities


possibie
volatiiity
company
'
sstock
price


concentration
ownership


potentia
|fiuctuationin
company
'
operating
results


publisher
report
doesnot
represent
information
contained
message
states
al
|material
facts
omit
material
fact
necessary
make
thestatements
therein
misieading


|
|
information
provided
within
thisreport
pertaining
investing


stocks


securities
understoodas
information
provided
investment
advice


pubiisher
ofthisnewsletter
advises
readers
subscribers
seek
advice
aregistered
professiona
|
securities
representative
before
deciding
totrade
stocks
featured
within
report


none
materia
|withinthis
report
shall
construed
kind
investment
advice
orsolicitation


many
companies
verge
bankruptcy

canlose
money
investing
stock


publisher
thisreport
registered
investment
expert


subscribers
notview
information
herein
|
egal


tax


accounting
investment
advice

reference
past
performance




companies
speciailyselectedto
referenced
based
favorabie
performance
companies

need
perfect
timing
achieve
resuits
exampiesgiven


assurance
happening


remember


asalways

past
performance
indicative
future
resuits
thorough
duediligence
effort


including
review
company
'
fiiings
sec
govor
edgar


oniine
com
availabie


completed
prior
toinvesting


factua
|
information
report
gathered
frompubiicsources


including
|
imited
company
websites
companypressreleases


publisher
report
believes
information
bereiiable
make
assurance
accuracy
completeness

use
material
within
report
constitutes
acceptance
ofthese
terms


compliance
securities
act
1933


sectionl
7b


publisher
newsletter
discioses
receipt
tenthousand
|
|
ars
third
party


officer


director
oraffiiiatesharehoider
circulation
report


aware
inherentconfiict
interest
resulting
compensation
due
factthat
paid
advertisement
without
bias


partythatpaid
position
stock
wi
|
|
sel
|
anytime
withoutnotice


negative
impact
price
stock

wish
stop
future
mailings


feel
beenwrongfully
placed
membership


please
go
here
send
blanke
mai
|
thanks
subject




stock
04
@
yahoo


com
